AYERST RESHUFFLES IN CANADIAN MERGER
Ayerst Laboratories is creating 90 jobs and losing 17 others in St Laurent in Canada in a reshuffle of its drug manufacturing and marketing operations. Production is to be increased gradually as part of its merger with Wyeth, based in Windsor, Ontario, to form Wyeth-Ayerst Canada. The two companies are subsidiaries of American Home Products of the USA.
The Wyeth plant in Windsor will close in July, according to local reports which say the St Laurent plant is much larger. There will also be a relocation of 17 marketing and sales positions from Montreal to Toronto where the merged marketing operations will be based.
Ayerst Labs is reported to spend C$20 million ($15.8 million) on R&D annually, representing around 11% of prescription drug sales in Canada.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze